Related Experiment Video
Updated: Nov 27, 2025

08:48
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
3.2K
BIOCHEMICAL ASPECTS OF SYMPTOMATIC TREATMENT IN PATIENTS WITH COVID-19 (REVIEW)
G Burjanadze1, N Kuridze2, D Goloshvili1
11Tbilisi State Medical University; Georgia.
Georgian Medical News
|December 3, 2020
Summary
The novel Coronavirus (SARS-CoV-2) causes COVID-19, a severe disease with no vaccine or specific treatment. Prevention through social distancing is key to combating its high lethality, especially in older adults.
Area of Science:
- Virology
- Infectious Diseases
- Public Health
Background:
- The emergence of SARS-CoV-2 has presented significant challenges to global health systems.
- COVID-19 exhibits high lethality, particularly impacting elderly populations.
- The absence of vaccines and specific treatments underscores the critical need for effective prevention strategies.
Purpose of the Study:
- To review the characteristics of SARS-CoV-2, including its invasion mechanisms and pathogenesis.
- To explore the biochemical and pharmacological aspects of symptomatic treatment for COVID-19.
- To synthesize existing research, author viewpoints, and propose new perspectives for combating the virus.
Main Methods:
- Literature review of scientific articles and studies on SARS-CoV-2 and COVID-19.
- Analysis of viral features, pathogenesis, and host-virus interactions.
- Examination of pharmacological data and mechanisms of action for various treatments.
Main Results:
- SARS-CoV-2 is highly virulent and contagious, necessitating social distancing.
- The article details viral entry pathways and disease pathogenesis.
- Discussion includes diverse scientific opinions on treatment efficacy and impact.
Conclusions:
- Prevention, primarily through social distancing, remains the most crucial measure against COVID-19.
- Understanding viral mechanisms and treatment options is vital for managing the pandemic.
- Further research and consensus-building are needed to refine therapeutic strategies and outcomes.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
84
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
84
Myocarditis II: Clinical Features and Diagnostic Tests
115
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
115
Pneumonia IV: Management
600
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
600
Controls in Experiments
14.4K
When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
14.4K
Conjugated Proteins
24.4K
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
24.4K
Alzheimer's Disease: Treatment
596
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
596

